A novel approach for addressing Alzheimer's disease: The chemo-optical synergism

Journal of Neuroscience Research

Volumn 90, Issue 7, 2012, Pages 1297-1298

  Sommer, Andrei P ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; EPIGALLOCATECHIN GALLATE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN LEVEL; CANCER CELL; DRUG PENETRATION; HUMAN; IN VITRO STUDY; IRRADIATION; LASER; LOW LEVEL LASER THERAPY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN AGGREGATION; TEA; TRAUMATIC BRAIN INJURY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CATECHIN; HUMANS; LASER THERAPY; NEUROPROTECTIVE AGENTS;

EID: 84860916306     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23044     Document Type: Note

References (14)

1. Allen CL, Bayraktutan U. 2009. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 4: 461-470.
2. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A, Wanker EE. 2008. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15: 558-566.
3. Friedrich RP, Tepper K, Rönicke R, Soom M, Westermann M, Reymann K, Kaether C, Fändrich M. 2010. Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc Natl Acad Sci U S A 107: 1942-1947.
4. Haass C, Selkoe DJ. 2007. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112.
5. Karu T, Pyatibrat L, Kalendo G. 1995. Irradiation with He-Ne laser increases ATP level in cells cultivated in vitro. J Photochem Photobiol B 27: 219-223.
6. Lapchak PA. 2012. Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases. Expert Rev Med Devices 9: 71-83.
7. Lulevich V, Zimmer CC, Hong HS, Jin LW, Liu GY. 2010. Single-cell mechanics provides a sensitive and quantitative means for probing amyloid-beta peptide and neuronal cell interactions. Proc Natl Acad Sci U S A 107: 13872-13877.
8. Miller G. 2011. Neuropathology. A battle no soldier wants to fight. Science 333: 517-519.
9. Oron A, Oron U, Streeter J, De Taboada L, Alexandrovich A, Trembovler V, Shohami E. 2012. Near infrared transcranial laser therapy applied at various modes to mice following traumatic brain injury significantly reduces long-term neurological deficits. J Neurotrauma 29: 401-407.
10. Rauk A. 2008. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic? Dalton Trans 14: 1273-1282.
11. Sommer AP, Zhu D. 2009. Facial rejuvenation in the triangle of ROS. Crystal Growth Des 9: 4250-4254.
12. Sommer AP, Zhu D, Scharnweber T. 2010. Laser modulated transmembrane convection: Implementation in cancer chemotherapy. J Control Release 148: 131-134.
13. Sommer AP, Bieschke J, Friedrich RP, Zhu D, Wanker EE, Fecht HJ, Mereles D, Hunstein W. 2012. 670 nm Laser light and EGCG complementarily reduce amyloid-β aggregates in human neuroblastoma cells: basis for treatment of Alzheimer's disease? Photomed Laser Surg 30: 54-60.
14. Wong-Riley MT, Liang HL, Eells JT, Chance B, Henry MM, Buchmann E, Kane M, Whelan HT. 2005. Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: role of cytochrome c oxidase. J Biol Chem 280: 4761-4771.